did serena williams use glp-1 Is the Surprising New Face of Weight-Loss Drugs Serena Williams broke her silence

The pipeline continues to expand: Novo Nordisk filed an NDA for CagriSema (semaglutide + cagrilintide) in December 2025, which achieved 22.7% weight loss in the REDEFINE 1 trial, and Eli Lilly reported Phase 3 results for retatrutide , a triple GIP/GLP-1/glucagon agonist that delivered 28.7% weight loss

Given that reactive oxygen species (ROS) may trigger inflammation by promoting pro-inflammatory cytokines and activating the NF-B pathway, LCs antioxidant action indirectly reinforces its anti-inflammatory effects

Exogenous glutathione improves intracellular glutathione synthesis via the -glutamyl cycle in bovine zygotes and cleavage embryos

Swirl gently until the powder fully dissolves do not shake or vortex